Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Biological Products »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Biological Factors < Biological Products < Biological Therapy  Facettes :

List of bibliographic references indexed by Biological Products

Number of relevant bibliographic references: 255.
[40-60] [0 - 20][0 - 50][60-80]
Ident.Authors (with country if any)Title
001277 (2018) Seoyoung C. Kim [États-Unis] ; Daniel H. Solomon [États-Unis] ; James R. Rogers [États-Unis] ; Sara Gale [États-Unis] ; Micki Klearman [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis]No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.
001301 (2018) Lisa Baganz [Allemagne] ; Adrian Richter [Allemagne] ; Jörn Kekow [Allemagne] ; Arnold Bussmann [Allemagne] ; Andreas Krause [Allemagne] ; Carsten Stille [Allemagne] ; Joachim Listing [Allemagne] ; Angela Zink [Allemagne] ; Anja Strangfeld [Allemagne]Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
001334 (2018) Margarida Figueiredo-Braga [Portugal] ; Caleb Cornaby [États-Unis] ; Alice Cortez [Portugal] ; Miguel Bernardes [Portugal] ; Georgina Terroso [Portugal] ; Marta Figueiredo [Portugal] ; Cristina Dos Santos Mesquita [Portugal] ; Lúcia Costa [Portugal] ; Brian D. Poole [États-Unis]Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis.
001370 (2018) Ying-Chou Chen [Taïwan] ; Wen-Chan Chiu [Taïwan] ; Fu-Mei Su [Taïwan] ; Jia-Feng Chen [Taïwan]Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
001375 (2018) Yasuaki Okuda [Japon] ; Toshiyuki Yamada [Japon] ; Mitsuharu Ueda [Japon] ; Yukio Ando [Japon]First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
001392 (2018) Paul Emery [Royaume-Uni] ; Janet E. Pope [Canada] ; Klaus Kruger [Allemagne] ; Ralph Lippe [Allemagne] ; Ryan Demasi [États-Unis] ; Sadiq Lula [Royaume-Uni] ; Blerina Kola [Royaume-Uni]Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review.
001398 (2018) Guillaume Moulis [France] ; Grégory Pugnet [France] ; Nathalie Costedoat-Chalumeau [France] ; Alexis Mathian [France] ; Gaëlle Leroux [France] ; Jonathan Boutémy [France] ; Olivier Espitia [France] ; Laurence Bouillet [France] ; Sabine Berthier [France] ; Jean-Baptiste Gaultier [France] ; Pierre-Yves Jeandel [France] ; Amadou Konaté [France] ; Arsène Mékinian [France] ; Elisabeth Solau-Gervais [France] ; Benjamin Terrier [France] ; Daniel Wendling [France] ; Fanny Andry [France] ; Camille Garnier [France] ; Pascal Cathébras [France] ; Laurent Arnaud [France] ; Aurore Palmaro [France] ; Patrice Cacoub [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Philippe Arlet [France] ; Maryse Lapeyre-Mestre [France] ; Laurent Sailler [France]Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
001402 (2018) Sanjoy Ketan Paul [Australie] ; Olga Montvida [Australie] ; Jennie H. Best [États-Unis] ; Sara Gale [États-Unis] ; Attila Pethoe-Schramm [Suisse] ; Khaled Sarsour [États-Unis]Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data.
001408 (2018) Grant S. Schulert [États-Unis] ; Francesca Minoia [Italie] ; John Bohnsack ; Randy Q. Cron ; Soah Hashad [Libye] ; Isabelle Koné-Paut [France] ; Mikhail Kostik [Russie] ; Daniel Lovell [États-Unis] ; Despoina Maritsi [Grèce] ; Peter A. Nigrovic [États-Unis] ; Priyankar Pal [Inde] ; Angelo Ravelli [Italie] ; Masaki Shimizu [Japon] ; Valda Stanevicha [Lettonie] ; Sebastiaan Vastert [Pays-Bas] ; Andreas Woerner [Suisse] ; Fabrizio De Benedetti [Italie] ; Alexei A. Grom [États-Unis]Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
001412 (2018) Drugs for rheumatoid arthritis.
001414 (2018) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Akira Ohnishi [Japon] ; Daijiro Kabata [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Kengo Akashi [Japon] ; Takanori Fujimura [Japon] ; Makoto Hirao [Japon] ; Keiichi Yamamoto [Japon] ; Ayumi Shintani [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
001415 (2018) Der-Yuan Chen [Taïwan] ; Chak Sing Lau [Hong Kong] ; Bassel Elzorkany [Égypte] ; Ping-Ning Hsu [Taïwan] ; Sonja Praprotnik [Slovénie] ; Radu Vasilescu [Belgique] ; Lisa Marshall [États-Unis] ; Lyndon Llamado [Philippines]Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature.
001435 (2018) Tao Gu [États-Unis] ; Alex Mutebi ; Bradley S. Stolshek ; Hiangkiat TanCost of biologic treatment persistence or switching in rheumatoid arthritis.
001446 (2018) Ettore Silvagni [Italie] ; Alessandra Bortoluzzi [Italie] ; Greta Carrara [Italie] ; Anna Zanetti [Italie] ; Marcello Govoni [Italie] ; Carlo Alberto Scirè [Italie]Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
001510 (2018) Graeme Jones [Australie] ; Stephen Hall [Australie] ; Paul Bird [Australie] ; Geoff Littlejohn [Australie] ; Kathleen Tymms [Australie] ; Peter Youssef [Australie] ; Eric Chung [Australie] ; Rina Barrett [Australie] ; Peter Button [Australie]A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.
001560 (2017) Cosimo Bruni [Italie] ; Emanuela Praino [Italie] ; Yannick Allanore [France] ; Oliver Distler [Suisse] ; Armando Gabrielli [Italie] ; Florenzo Iannone [Italie] ; Marco Matucci-Cerinic [Italie]Use of biologics and other novel therapies for the treatment of systemic sclerosis.
001561 (2017) Mari Kihara [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath D. Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
001582 (2017) Ernest H. Choy [Royaume-Uni] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jose Fernando Molina [Colombie] ; Oscar Massimiliano Epis [Italie]Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.
001583 (2017) Benjamin Chastek [États-Unis] ; Chieh-I Chen [États-Unis] ; Clare Proudfoot [Royaume-Uni] ; Shraddha Shinde [États-Unis] ; Andreas Kuznik [États-Unis] ; Wenhui Wei [États-Unis]Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA.
001621 (2017) Yuan An [République populaire de Chine] ; Tian Liu [République populaire de Chine] ; Dongyi He [République populaire de Chine] ; Lijun Wu [République populaire de Chine] ; Juan Li [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Liqi Bi [République populaire de Chine] ; Bin Zhou [République populaire de Chine] ; Changsong Lin [République populaire de Chine] ; Lan He [République populaire de Chine] ; Xiangyuan Liu [République populaire de Chine] ; Xiaofeng Li [République populaire de Chine] ; Niansheng Yang [République populaire de Chine] ; Zhuoli Zhang [République populaire de Chine] ; Hui Song [République populaire de Chine] ; Wei Wei [République populaire de Chine] ; Jing Liu [République populaire de Chine] ; Yu Bi [République populaire de Chine] ; Zhanguo Li [République populaire de Chine]The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.
001626 (2017) Chong Hong Lim [Malaisie] ; Hsin-Hua Chen [Taïwan] ; Yi-Hsing Chen [Taïwan] ; Der-Yuan Chen [Taïwan] ; Wen-Nan Huang [Taïwan] ; Jaw-Ji Tsai [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Wei-Ting Hung [Taïwan] ; Ching-Tsai Lin [Taïwan] ; Kuo-Lung Lai [Taïwan] ; Kuo-Tung Tang [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Yi-Ming Chen [Taïwan]The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Biological Products" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Biological Products" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Biological Products
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021